Soler, Arjilyn .
HRN: 20-41-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2024
CEFUROXIME 500MG (TAB)
01/22/2024
01/28/2024
PO
500mg
Bid
S/p Rmle With Repair
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes